Namodenoson in Advanced Hepatocellular Carcinoma and Child–Pugh B Cirrhosis: Randomized Placebo-Controlled Clinical Trial
Namodenoson, an A3 adenosine-receptor agonist, showed promising results in advanced hepatocellular carcinoma (HCC) and moderate hepatic dysfunction (Child–Pugh B; CPB) in a phase I/II clinical study. This phase II study investigated namodenoson as second-line therapy in such patients. Patients were...
Main Authors: | Salomon M. Stemmer, Nebojsa S. Manojlovic, Mihai Vasile Marinca, Petar Petrov, Nelly Cherciu, Doina Ganea, Tudor Eliade Ciuleanu, Ioana Adriana Pusca, Muhammad Shaalan Beg, William T. Purcell, Adina-Emilia Croitoru, Rumyana Nedyalkova Ilieva, Sladjana Natošević, Amedeia Lavinir Nita, Dimitar Nikolaev Kalev, Zivit Harpaz, Motti Farbstein, Michael H. Silverman, David Bristol, Inbal Itzhak, Pnina Fishman |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2021-01-01
|
Series: | Cancers |
Subjects: | |
Online Access: | https://www.mdpi.com/2072-6694/13/2/187 |
Similar Items
-
Pugh, Tison: <em>Innocence, Heterosexuality, and the Queerness of Children’s Literature</em>
by: Mia Österlund
Published: (2013-05-01) -
Chronic hepatitis B and D: prognosis according to Child-Pugh score
by: Marcelo Siqueira de Oliveira, et al. -
Relationship between intestinal dysbacteriosis and Child-Pugh classification in patients with cirrhosis
by: HUANG Xiaoyu
Published: (2015-03-01) -
The effect of Child-Pugh classification on colorectal cancer surgery: A meta-analysis
by: Xiao-Yu Liu, et al.
Published: (2021-06-01) -
Correlation of Serum Prolactin Level to Child Pugh Scoring System in Cirrhosis of Liver
by: CHAITANYA H. BALAKRISHNAN, et al.
Published: (2017-07-01)